Lorazepam
Back to searchMolecule Structure
Scientific Name
Lorazepam
Description of the Drug
Lorazepam is a short-acting benzodiazepine commonly used to treat panic disorders, severe anxiety, and seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00186
http://www.drugbank.ca/drugs/DB00186
Brand Name(s)
Abbloraz, Ativan, Loraz, Lorazepam, Lorazepam intensol, Lorazepam preservative free, Loreev xr, Temesta
Company Owner(s)
Dava Pharmaceuticals Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Aurolife Pharma Llc, Akorn Operating Co Llc, Bedford Laboratories Div Ben Venue Laboratories Inc, Rising Pharma Holdings Inc, Pharmaceutical Assoc Inc, Warner Chilcott Div Warner Lambert Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL26961 | |
PharmGKB | PA450267 | |
Human Metabolome Database | HMDB0014332 | |
DrugBank | DB00186 | |
PubChem: Thomson Pharma | 14801418 | |
PubChem | 3958 | |
NMRShiftDB | 60059404 | |
LINCS | LSM-4970 | |
Nikkaji | J3.337E | |
BindingDB | 50292627 | |
EPA CompTox Dashboard | DTXSID7023225 | |
DrugCentral | 1606 | |
Brenda | 8612 | |
Guide to Pharmacology | 5884 | |
rxnorm | ATIVAN | LORAZEPAM |
ChEBI | 6539 |